Literature DB >> 15110319

Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.

Daan M van den Brink1, Joram N I van Miert, Georges Dacremont, Jean-François Rontani, Gerbert A Jansen, Ronald J A Wanders.   

Abstract

Phytol is a branched chain fatty alcohol, which is abundantly present in nature as part of the chlorophyll molecule. In its free form, phytol is metabolized to phytanic acid, which accumulates in patients suffering from a variety of peroxisomal disorders, including Refsum disease. The breakdown of phytol to phytanic acid takes place in three steps, in which first, the alcohol is converted to the aldehyde, second the aldehyde is converted to phytenic acid, and finally the double bond is reduced to yield phytanic acid. By culturing fibroblasts in the presence of phytol, increases in the levels of phytenic and phytanic acid were detected. Interestingly, fibroblasts derived from patients affected by Sjögren Larsson syndrome (SLS), known to be deficient in microsomal fatty aldehyde dehydrogenase (FALDH) were found to be deficient in this. In addition, fibroblast homogenates of these patients, incubated with phytol in the presence of NAD+ did not produce any phytenic acid. This indicates that FALDH is involved in the breakdown of phytol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110319     DOI: 10.1016/j.ymgme.2004.01.019

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  15 in total

1.  A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.

Authors:  D M van den Brink; J M van Miert; R J A Wanders
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Authors:  Tatsuro Naganuma; Shuyu Takagi; Tsukasa Kanetake; Takuya Kitamura; Satoko Hattori; Tsuyoshi Miyakawa; Takayuki Sassa; Akio Kihara
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

Review 3.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

Review 4.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

Review 5.  Sjögren-Larsson syndrome in clinical practice.

Authors:  Joris Fuijkschot; Thomas Theelen; Marieke M B Seyger; Marinette van der Graaf; Imelda J M de Groot; Ron A Wevers; Ronald J A Wanders; Hans R Waterham; Michèl A A P Willemsen
Journal:  J Inherit Metab Dis       Date:  2012-07-26       Impact factor: 4.982

6.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

7.  Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.

Authors:  William B Rizzo; Debra A Craft; Tara Somer; Gael Carney; Juliana Trafrova; Marcia Simon
Journal:  J Lipid Res       Date:  2007-10-30       Impact factor: 5.922

8.  Two D-2-hydroxy-acid dehydrogenases in Arabidopsis thaliana with catalytic capacities to participate in the last reactions of the methylglyoxal and beta-oxidation pathways.

Authors:  Martin Engqvist; María F Drincovich; Ulf-Ingo Flügge; Verónica G Maurino
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

Review 9.  Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

Authors:  William B Rizzo
Journal:  Biochim Biophys Acta       Date:  2013-09-12

10.  The role of fatty aldehyde dehydrogenase in epidermal structure and function.

Authors:  William B Rizzo
Journal:  Dermatoendocrinol       Date:  2011-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.